Specific code 2015 ICD-9-CM Diagnosis Code 161.1
Malignant neoplasm of supraglottis
  • 2015
  • Billable Thru Sept 30/2015
  • Non-Billable On/After Oct 1/2015

  • ICD-9-CM 161.1 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 161.1 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
Convert to ICD-10-CM: 161.1 converts directly to:
  • 2015/16 ICD-10-CM C32.1 Malignant neoplasm of supraglottis
Approximate Synonyms
  • Cancer of the epiglottis
  • Cancer of the supraglottis
  • Laryngeal cancer, epiglottis
  • Laryngeal cancer, supraglottis
  • Primary malignant neoplasm of epiglottis
  • Primary malignant neoplasm of supraglottis
Clinical Information
  • A primary or metastatic malignant neoplasm involving the supraglottis
161.1 Excludes
  • anterior aspect of epiglottis (146.4)
  • aryepiglottic fold or interarytenoid fold:
Applies To
  • Aryepiglottic fold or interarytenoid fold, laryngeal aspect
  • Epiglottis (suprahyoid portion) NOS
  • Extrinsic larynx
  • False vocal cords
  • Posterior (laryngeal) surface of epiglottis
  • Ventricular bands
ICD-9-CM codes are used in medical billing and coding to describe diseases, injuries, symptoms and conditions. ICD-9-CM 161.1 is one of thousands of ICD-9-CM codes used in healthcare. Although ICD-9-CM and CPT codes are largely numeric, they differ in that CPT codes describe medical procedures and services. Can't find a code? Start at the root of ICD-9-CM, check the 2015 ICD-9-CM Index or use the search engine at the top of this page to lookup any code.